GSK PLC SP. ADR/2 NEW (GS70) — Free Cash Flow Generation Index
GSK PLC SP. ADR/2 NEW (GS70) has a Free Cash Flow Generation Index of 0.76x as of June 2026. Free cash flow of €2.04 Billion represents 1% of operating cash flow (€2.69 Billion). Explore GSK PLC SP. ADR/2 NEW (GS70) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GSK PLC SP. ADR/2 NEW Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for GSK PLC SP. ADR/2 NEW across 5 annual periods. For the full cash flow conversion analysis, see GSK PLC SP. ADR/2 NEW operating cash flow efficiency.
Annual Free Cash Flow Generation for GSK PLC SP. ADR/2 NEW (2021–2025)
Year-by-year Free Cash Flow Generation Index for GSK PLC SP. ADR/2 NEW. Check GS70 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | €4.76 Billion | €7.74 Billion | €2.98 Billion | ▲ +12.7% |
| 2024 | 0.55x | €3.57 Billion | €6.55 Billion | €2.98 Billion | ▼ -16.6% |
| 2023 | 0.65x | €4.42 Billion | €6.77 Billion | €2.34 Billion | ▼ -5.9% |
| 2022 | 0.69x | €5.14 Billion | €7.40 Billion | €2.26 Billion | ▲ +4.3% |
| 2021 | 0.67x | €5.30 Billion | €7.95 Billion | €2.65 Billion | — |